Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Locally Advanced Unresectable Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00623558
What this trial is testing

Cetuximab as Induction Treatment in Head and Neck Squamous Cell Carcinoma (HNSCC)

Who this might be right for
Head and Neck Neoplasm
Seoul National University Hospital 92
Testing effectiveness (Phase 2)UnknownNCT04844385
What this trial is testing

Toripalimab Plus Neoadjuvant Chemotherapy Combined With Chemoradiotherapy for Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Sun Yat-sen University 124
Testing effectiveness (Phase 2)Looking for participantsNCT05655949
What this trial is testing

Y-90 With Durvalumab/Gem/Cis in Intrahepatic Cholangio

Who this might be right for
Bile Duct CancerCholangiocarcinomaCholangiocarcinoma Non-resectable+2 more
Beth Israel Deaconess Medical Center 30
Testing effectiveness (Phase 2)Looking for participantsNCT07530094
What this trial is testing

Short-Course Definitive Chemoradiotherapy Combined With Adjuvant or Concurrent Plus Adjuvant Camrelizumab for Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma

Who this might be right for
Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma
Ning Jiang, M.D./Ph.D. 98
Testing effectiveness (Phase 2)Active Not RecruitingNCT04068194
What this trial is testing

Testing the Combination of New Anti-cancer Drug Peposertib With Avelumab and Radiation Therapy for Advanced/Metastatic Solid Tumors and Hepatobiliary Malignancies

Who this might be right for
Locally Advanced Malignant Solid NeoplasmLocally Advanced Unresectable CholangiocarcinomaLocally Advanced Unresectable Gallbladder Carcinoma+7 more
National Cancer Institute (NCI) 103
Early research (Phase 1)UnknownNCT05867303
What this trial is testing

A RC198 Study in Subjects With Locally Advanced Unresectable or Metastatic Solid Tumors

Who this might be right for
MelanomaUrothelial CarcinomaRenal Cell Carcinoma+3 more
RemeGen Co., Ltd. 48
Testing effectiveness (Phase 2)Looking for participantsNCT05422690
What this trial is testing

The Purpose of This Research Study is to See if Combining Gemcitabine, Cisplatin and Durvalumab Chemotherapy Treatments With a Direct Tumor Therapy Yittrium-90 (Y-90) Will Work Better Together to Shrink Tumors and Control Cancer

Who this might be right for
Intrahepatic Cholangiocarcinoma
Inova Health Care Services 16
Not applicableStudy completedNCT03788746
What this trial is testing

Prevalence of PD-L1 Expression in Patients With Advanced Urothelial Carcinoma

Who this might be right for
Urothelial Carcinoma
AstraZeneca 181
Early research (Phase 1)Looking for participantsNCT05098210
What this trial is testing

Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positive HER2 Negative Metastatic Refractory Breast Cancer or Stage III-IV Non-Small Cell Lung Cancer

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Locally Advanced Cutaneous Melanoma+22 more
Fred Hutchinson Cancer Center 28
Testing effectiveness (Phase 2)Looking for participantsNCT06912074
What this trial is testing

Hypofractionated vs. Conventional Chemoradiotherapy After Induction Chemo-immunotherapy for Unresectable Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)
Sun Yat-sen University 134
Testing effectiveness (Phase 2)UnknownNCT04839510
What this trial is testing

MRG002 in the Treatment of HER2-positive Unresectable Locally Advanced or Metastatic Urothelium Cancer

Who this might be right for
Locally Advanced Urothelial CancerMetastatic Urothelial Carcinoma
Shanghai Miracogen Inc. 58
Testing effectiveness (Phase 2)Study completedNCT05386888
What this trial is testing

A Trial of GFH018 and Toripalimab in Combination With Concurrent Chemoradiotherapy in Stage III NSCLC Chemoradiotherapy in Stage III NSCLC

Who this might be right for
NSCLC, Stage III
Genfleet Therapeutics (Shanghai) Inc. 65
Testing effectiveness (Phase 2)Looking for participantsNCT05756569
What this trial is testing

Enfortumab Vedotin Plus Pembrolizumab for the Treatment of Locally Advanced or Metastatic Bladder Cancer of Variant Histology

Who this might be right for
Bladder Squamous Cell CarcinomaLocally Advanced Bladder CarcinomaMalignant Renal Pelvis Neoplasm+8 more
Emory University 25
Testing effectiveness (Phase 2)Study completedNCT02577341
What this trial is testing

Nimotuzumab Combined With Chemoradiotherapy for Unresectable Locally Advanced Squamous Cell Lung Cancer

Who this might be right for
Non-small-cell Lung Cancer
Sun Yat-sen University 122
Large-scale testing (Phase 3)Study completedNCT00686959
What this trial is testing

Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Eli Lilly and Company 598
Large-scale testing (Phase 3)Study completedNCT03728556
What this trial is testing

CS1001 in Subjects With Stage III Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer Stage III
CStone Pharmaceuticals 381
Testing effectiveness (Phase 2)Study completedNCT01149083
What this trial is testing

Veliparib With or Without Carboplatin in Treating Patients With Stage III or IV Breast Cancer

Who this might be right for
Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8Locally Advanced Breast Carcinoma+2 more
National Cancer Institute (NCI) 77
Testing effectiveness (Phase 2)Ended earlyNCT01794845
What this trial is testing

Cetuximab + Taxotere With Low Dose Fractionated Radiation for Head and Neck Carcinoma

Who this might be right for
Squamous Cell CarcinomaHead and Neck CancerRecurrent Disease
University of Miami 5
Not applicableNo Longer AvailableNCT04667234
What this trial is testing

Expanded Access of Sotorasib

Who this might be right for
Non Small-cell Lung CancerLocally Advanced Unresectable NSCLCLocally Advanced Metastatic NSCLC
Amgen
Not applicableStudy completedNCT00253708
What this trial is testing

Massage Therapy in Treating the Symptoms of Patients With Locally Advanced or Metastatic Cancer

Who this might be right for
Cancer
Beth Israel Deaconess Medical Center 39
Next Page